Community-onset candidemia at a university hospital, 1995-2005

Journal of Microbiology, Immunology and Infection

Volumn 40, Issue 4, 2007, Pages 355-363

  Kung, Hsiang Chi ^a   Wang, Jiun Ling ^a   Chang, Shan Chwen ^a,b   Wang, Jann Tay ^a   Sun, Hsin Yun ^a   Hsueh, Po Ren ^a   Chen, Yee Chun ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Candidiasis; Cross infection; Fungemia; Infections, community acquired; Mortality; Risk factors

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; FLUCONAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOSUPPRESSIVE AGENT; MICAFUNGIN; PROTON PUMP INHIBITOR; STEROID;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANDIDA; CANDIDEMIA; CENTRAL VENOUS CATHETERIZATION; CHRONIC KIDNEY FAILURE; CHRONIC LUNG DISEASE; COMMUNITY; DIABETES MELLITUS; DIGESTIVE SYSTEM ULCER; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRAIN; FEMALE; FUNGUS ISOLATION; GASTROINTESTINAL HEMORRHAGE; HEMATOPOIETIC SYSTEM TUMOR; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTPATIENT; PARENTERAL NUTRITION; RISK FACTOR; SOLID TUMOR; STEROID THERAPY; TAIWAN; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; UNIVERSITY HOSPITAL; URINARY TRACT OBSTRUCTION; URINE CATHETER; WHOLE BODY RADIATION;

ADULT; AGED; AGED, 80 AND OVER; CANDIDA; CANDIDIASIS; CAUSALITY; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; CROSS INFECTION; FEMALE; FUNGEMIA; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TAIWAN;

EID: 35748965315     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Morgan J. Global trends in candidemia: review of reports from 1995-2005. Curr Infect Dis Rep. 2005;7:429-39.
2. Chen YC, Chang SC, Sun CC, Yang LS, Hsieh WC, Luh KT. Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993. Infect Control Hosp Epidemiol. 1997;18:369-75.
3. Colombo AL, Nucci M, Salomão R, Branchini ML, Richtmann R, Derossi A, et al. High rate of non-albicans candidemia in Brazilian tertiary care hospitals. Diagn Microbiol Infect Dis. 1999;34:281-6.
4. Kao AS, Brandt ME, Pruitt WR, Conn LA, Perkins BA, Stephens DS, et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis. 1999;29:1164-70.
5. Pfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, Hollis RJ, et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol. 2001; 39:3254-9.
6. Macphail GL, Taylor GD, Buchanan-Chell M, Ross C, Wilson S, Kureishi A. Epidemiology, treatment and outcome of candidemia: a five-year review at three Canadian hospitals. Mycoses. 2002;45:141-5.
7. Richet H, Roux P, Des Champs C, Esnault Y, Andremont A. Candidemia in French hospitals: incidence rates and characteristics. Clin Microbiol Infect. 2002;8:405-12.
8. Diekema DJ, Messer SA, Brueggemann AB, Coffman SL, Doern GV, Herwaldt LA, et al. Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol. 2002;40: 1298-302.
9. Alonso-Valle H, Acha O, García-Palomo JD, Fariñas-Alvarez C, Fernández-Mazarrasa C, Fariñas MC. Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality. Eur J Clin Microbiol Infect Dis. 2003;22:254-7.
10. Bader MS, Lai SM, Kumar V, Hinthorn D. Candidemia in patients with diabetes mellitus: epidemiology and predictors of mortality. Scand J Infect Dis. 2004;36:860-4.
11. Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA, et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol. 2004;42: 1519-27.
12. Pasqualotto AC, Nedel WL, Machado TS, Severo LC. A comparative study of risk factors and outcome among outpatient-acquired and nosocomial candidaemia. J Hosp Infect. 2005;60:129-34.
13. Hung CC, Chen YC, Chang SC, Luh KT, Hsieh WC. Nosocomial candidemia in a university hospital in Taiwan. J Formos Med Assoc. 1996;95:19-28.
14. Horan TC, Gaynes RP. Surveillance of nosocomial infections. In: Mayhall CG, ed. Hospital epidemiology and infection control, 3rd ed.,. Philadelphia: Lippincott Williams & Wilkins; 2004;1659-1702. 2004 NNIS definitions also available from: http://www.cdc.gov/ncidod/dhqp/pdf/nnis/NosInfdefinitions. pdf
15. Siegman-Igra Y, Fourer B, Orni-Wasserlauf R, Golan Y, Noy A, Schwartz D, et al. Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis. 2002;34:1431-9.
16. Ellenberg E. Nosocomial infection: a terminological clarification. Lancet Infect Dis. 2004;4:721.
17. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137: 791-7.
18. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis. 2003;36:131-9.
19. Hilf, M, Yu VL, Sharp J, Zuravleff JJ, Korvick JA, Muder RR. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med. 1989;87:540-6.
20. Korvick JA, Bryan CS, Farber B, Beam TR, Schenfeld L, Muder RR, et al. Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrob Agents Chemother. 1992;36: 2639-44.
21. Nguyen MH, Peacock JE, Tanner DC, Morris AJ, Nguyen ML, Snydman DR, et al. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med. 1995;155:2429-35.
22. Chen YC, Chang SC, Luh KT, Hsieh WC. Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years. J Antimicrob Chemother. 2003; 52:71-7.
23. Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis. 2004;38: 311-20.
24. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med. 1989;149:2349-53.
25. Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med. 1994;331:1325-30.
26. Yamamura DL, Rotstein C, Nicolle LE, Ioannou S. Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society. CMAJ. 1999;160:493-9.
27. Rivett AG, Perry JA, Cohen J. Urinary candidiasis: a prospective study in hospital patients. Urol Res. 1986;14:183-6.
28. Chen YC, Chang SC, Tai HM, Hsueh PR, Luh KT. Molecular epidemiology of Candida colonizing critically ill patients in intensive care units. J Formos Med Assoc. 2001;100:791-7.
29. Ang BS, Telenti A, King B, Steckelberg JM, Wilson WR. Candidemia from a urinary tract source: microbiological aspects and clinical significance. Clin Infect Dis. 1993;17:662-6.
30. Chang FY, MacDonald BB, Peacock JE, Musher DM, Triplett P, Mylotte JM, et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore). 2003;82:322-32.